News-Medical.Net on MSN
New targeted alpha therapy shows promise for patients with radioiodine-refractory thyroid cancer
A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback